American depositary receipts of European stocks were trading 0.47% lower at 125.81 on the Bank of New York Mellon Europe ADR Index on Friday.
In continental Europe, the gainers were led by biotech company ERYTECH Pharma ( ERYP ), and medical equipment company Edap ( EDAP ), which climbed 4.8% each. They were followed by semiconductor company Sequans Communications ( SQNS ), and marketing firm Criteo ( CRTO ), which rose 3% and 1.5%.
The decliners in continental Europe were led by pharmaceutical firm Oasmia Pharmaceutical ( OASM ), and biotech company Zealand Pharma (ZEAL), which lost 4.7% and 3.9% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT), and Deutsche Bank (DB), which were off 3.2% and 3.1%.
In the UK and Ireland, the gainers were led by biopharmaceutical company Motif Bio (MTFB), and pharmaceutical company Avadel (AVDL), which rose 6.6% and 2.6% respectively. They were followed by telecommunications provider Vodafone Group (VOD), and biopharmaceutical firm NuCana (NCNA), which were up 1.7% and 1%.
The decliners in the UK and Ireland were led by Barclays Bank (BCS), and gene therapy company Nightstar (NITE), which were down 3.3% and 2.8% respectively. They were followed by Lloyds Banking Group (LYG), and construction materials supplier CRH (CRH), which shed 2.3% and 2.2%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.